A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands-Reference-Cited by-同舟云学术

A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands

Published:2014-06-25 Issue:14 Volume:171 Page:3364-3375
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Swinney David C¹²,Beavis Paul¹,Chuang Kai-Ting¹,Zheng Yue¹,Lee Ina¹,Gee Peter¹,Deval Jerome¹,Rotstein David M¹,Dioszegi Marianna¹,Ravendran Palani¹,Zhang Jun¹,Sankuratri Surya¹,Kondru Rama¹,Vauquelin Georges³

Affiliation:

1. Roche Palo Alto; Palo Alto CA USA

2. Institute for Rare and Neglected Diseases Drug Discovery; Mountain View CA USA

3. Department of Molecular and Biochemical Pharmacology; Vrije Universiteit Brussel; Brussels Belgium

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12683/fullpdf

Reference45 articles.

1. The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors;Alexander;Br J Pharmacol,2013

2. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction;Cheng;Biochem Pharmacol,1973

3. The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety;Copeland;Expert Opin Drug Discov,2010

4. Conformational adaptation in drug-target interactions and residence time;Copeland;Future Med Chem,2011

5. Drug-target residence time and its implications for lead optimization;Copeland;Nat Rev Drug Discov,2006

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical and biophysical interaction of rare earth elements with biomacromolecules: A comprehensive review;Chemosphere;2024-06

2. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3;Molecular Pharmacology;2024-02-12

3. Pharmacological characterization and radiolabeling of VUF15485, a high-affinity small-molecule agonist for the atypical chemokine receptor ACKR3;MOL PHARMACOL;2023-07-12

4. Competition between induced fit- and conformational selection binding: how different flux-based approaches help clarifying their interplay;2023-07-01

5. The nanomolar affinity of C-phycocyanin from virtual screening of microalgal bioactive as potential ACE2 inhibitor for COVID-19 therapy;Journal of King Saud University - Science;2023-04